- SEK6.80bn
- SEK11.22bn
- SEK11.00bn
Brief: Arjo Receives 510K Clearance From US FDA For Woundexpress
Brief: Arjo April-June Net Sales Amounted To Sek 2,199 M (2,264)
Brief: Arjo AB (Publ) - Q1 Net Sales Sek 2.2 Million
Brief: Arjo Q4 Adjusted EBITDA Up At SEK 530 Mln
Brief: Arjo Acquires AirPal
Brief: Arjo Presents Updated Strategy And New Financial Targets For 2021-2023
Brief: Arjo July-Sept Adjusted EBITDA Up At SEK 448 Mln
Brief: Arjo Acquires Equity Stake In Bruin Biometrics
Brief: Arjo Signs Distribution Agreement With Brainlit
Brief: Arjo - Q2 Adjusted.EBITDA SEK 489 Million
Sweden's Arjo expects operating profit to rise more than 30% in Q2
Brief: Arjo Operating Profit For Q2 Estimated To Be Significantly Better Than Expected
Brief: Arjo Q1 Adj. EBITDA Up At SEK 445 Mln
Brief: Arjo Postpones Annual General Meeting And Capital Markets Day
Brief: Arjo Appoints Daniel Fäldt New CFO
Brief: Arjo Starts Randomized Controlled Trial For Wound Care Treatment
Brief: Arjo Q4 Adjusted EBITDA Increases 25.4% TO SEK 513 Mln
Brief: Daniel Fäldt Appointed CFO At Arjo
Brief: Arjo: Jonas Lindqvist To Leave CFO Position